KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to 0.74.

  • Resmed's Equity Ratio rose 105.5% to 0.74 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.74, marking a year-over-year increase of 105.5%. This contributed to the annual value of 0.73 for FY2025, which is 315.11% up from last year.
  • Per Resmed's latest filing, its Equity Ratio stood at 0.74 for Q4 2025, which was up 105.5% from 0.74 recorded in Q3 2025.
  • Resmed's 5-year Equity Ratio high stood at 0.74 for Q4 2025, and its period low was 0.56 during Q4 2022.
  • For the 5-year period, Resmed's Equity Ratio averaged around 0.67, with its median value being 0.66 (2022).
  • Per our database at Business Quant, Resmed's Equity Ratio skyrocketed by 1809.88% in 2021 and then tumbled by 1572.64% in 2022.
  • Resmed's Equity Ratio (Quarter) stood at 0.66 in 2021, then decreased by 15.73% to 0.56 in 2022, then grew by 15.92% to 0.65 in 2023, then grew by 13.33% to 0.74 in 2024, then grew by 1.05% to 0.74 in 2025.
  • Its Equity Ratio stands at 0.74 for Q4 2025, versus 0.74 for Q3 2025 and 0.73 for Q2 2025.